Cyrille Tupin

Vorstandsvorsitzender bei ABIONYX PHARMA

Vermögen: 2 Mio $ am 31.05.2024

48 Jahre

Health Technology

Commercial Services

Aktive Positionen von Cyrille Tupin

Unternehmen	Position	Beginn	Ende
ABIONYX PHARMA	Vorstandsvorsitzender	06.09.2019	-
	Direktor/Vorstandsmitglied	06.09.2019	-
	Investor Relations Kontakt	-	-
	Verwaltungsdirektor	01.01.2007	06.09.2019
	Finanzdirektor/CFO	01.01.2007	06.09.2019
Cerenis Therapeutics, Inc. Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI.	Vorstandsvorsitzender	-	-

Unternehmen	Position	Beginn	Ende
PricewaterhouseCoopers LLP PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY.	Corporate Officer/Principal	-	-

International

Operativ

Chief Executive Officer	3
Chief Administrative Officer	1
Director/Board Member	1

Sektoral

Health Technology	3
Commercial Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ABIONYX PHARMA	Health Technology

Private Unternehmen	2
PricewaterhouseCoopers LLP PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY.	Commercial Services
Cerenis Therapeutics, Inc. Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI.	Health Technology

Private Unternehmen

Commercial Services

Health Technology